Literature DB >> 6970019

Monitoring heparin anticoagulation and its neutralization.

D R Jobes, A J Schwartz, N Ellison, R Andrews, R A Ruffini, J J Ruffini.   

Abstract

Heparin anticoagulation and its neutralization were monitored by three different techniques: a manual protamine titration, an automated activated coagulation time, and an automated protamine titration. All three techniques provided satisfactory information. The decision of which to use must be based on other considerations such as available manpower and cost of equipment. The effect of using the automated protamine titration test on heparin and protamine requirements, and on blood loss measured intraoperatively after bypass and in overnight chest bottle drainage in two groups of comparable patients undergoing coronary artery bypass operation was studied. The heparin requirements were similar (24,420 +/- 584 units, control group; 23,550 +/- 849 units, treatment group), but the protamine requirements were markedly different (429 +/- 14.7 mg, control; 258 +/- 10.4 mg, treatment; p < 0.05). There was no statistical difference in intraoperative blood loss or overnight chest bottle drainage.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6970019     DOI: 10.1016/s0003-4975(10)61536-6

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  An evaluation of two activated clotting time monitors during cardiac surgery.

Authors:  D L Reich; K Zahl; M H Perucho; D M Thys
Journal:  J Clin Monit       Date:  1992-01

Review 2.  Management and monitoring of anticoagulation for children undergoing cardiopulmonary bypass in cardiac surgery.

Authors:  Colleen E Gruenwald; Cedric Manlhiot; Lynn Crawford-Lean; Celeste Foreman; Leonardo R Brandão; Brian W McCrindle; Helen Holtby; Ross Richards; Helen Moriarty; Glen Van Arsdell; Anthony K Chan
Journal:  J Extra Corpor Technol       Date:  2010-03

3.  Blood transfusion requirements in coronary artery surgery with and without the activated clotting time (ACT) technique.

Authors:  D U Preiss; H Schmidt-Bleibtreu; P Berguson; G Metz
Journal:  Klin Wochenschr       Date:  1985-03-15

Review 4.  Engineering the Surface of Therapeutic "Living" Cells.

Authors:  Jooyeon Park; Brenda Andrade; Yongbeom Seo; Myung-Joo Kim; Steven C Zimmerman; Hyunjoon Kong
Journal:  Chem Rev       Date:  2018-01-16       Impact factor: 60.622

5.  Monitoring unfractionated heparin in pediatric patients with congenital heart disease having cardiac catheterization or cardiac surgery.

Authors:  G G Kim; S El Rouby; J Thompson; A Gupta; J Williams; D R Jobes
Journal:  J Thromb Thrombolysis       Date:  2010-05       Impact factor: 2.300

6.  Heparin concentration-based anticoagulation for cardiac surgery fails to reliably predict heparin bolus dose requirements.

Authors:  Sean Garvin; Daniel C FitzGerald; George Despotis; Prem Shekar; Simon C Body
Journal:  Anesth Analg       Date:  2009-10-27       Impact factor: 5.108

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.